Inhibitory effect of guanfacine, a central alpha-adrenoceptor agonist, on prolactin secretion stimulated by insulin-induced hypoglycemia

J Clin Endocrinol Metab. 1978 Sep;47(3):671-4. doi: 10.1210/jcem-47-3-671.

Abstract

In six normal male volunteers oral administration of an alpha-receptor agonist, guanfacine (1 mg/q.i.d. for 4 days), had no effect on PRL release induced by 5 mg metoclopramide iv. The same treatment with quanfacine in six other normal subjects significantly reduced PRL secretion stimulated by insulin-induced hypoglycemia (P less than 0.05). These results suggest that an adrenergic pathway, hypothalamic or extrahypothalamic, might be involved in the inhibitory control of PRL secretion.

MeSH terms

  • Adrenergic alpha-Agonists*
  • Adult
  • Guanfacine
  • Guanidines*
  • Humans
  • Hypoglycemia / chemically induced
  • Insulin*
  • Kinetics
  • Male
  • Metoclopramide
  • Phenylacetates*
  • Prolactin / metabolism*

Substances

  • Adrenergic alpha-Agonists
  • Guanidines
  • Insulin
  • Phenylacetates
  • Guanfacine
  • Prolactin
  • Metoclopramide